Download PDF
Am J Perinatol 2020; 37(03): 333-340
DOI: 10.1055/s-0039-3400310
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A New Scoring System for the Assessment of Neonatal Abstinence Syndrome

Prabhakar Kocherlakota 
1   Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York
2   Department of Pediatrics, The Regional Neonatal Intensive Care Unit, Maria Ferrari Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
,
Edward C. Qian
1   Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York
,
Vishwas C. Patel
1   Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York
,
Cosmina Mandru
2   Department of Pediatrics, The Regional Neonatal Intensive Care Unit, Maria Ferrari Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
,
Rolando E. Vilar
1   Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York
2   Department of Pediatrics, The Regional Neonatal Intensive Care Unit, Maria Ferrari Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
,
Gad Alpan
2   Department of Pediatrics, The Regional Neonatal Intensive Care Unit, Maria Ferrari Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
,
Edmund F. La Gamma
1   Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York
2   Department of Pediatrics, The Regional Neonatal Intensive Care Unit, Maria Ferrari Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
› Author Affiliations Funding None.
Further Information

Publication History

03 June 2019

07 October 2019

Publication Date:
27 November 2019 (online)

    Permissions and Reprints

Abstract

Objective This study aimed to evaluate the concordance of a new scoring system for neonatal abstinence syndrome (NAS) and NAS scores to the traditional Modified Finnegan Neonatal Abstinence Scoring Tool (M-FNAST) score. The NAS score is based on the physiology of withdrawal, with equal emphasis on behavior, and neurological signs.

Study Design The NAS scores for a control group of 202 healthy, term neonates were compared with those for 45 term neonates with NAS. The NAS and M-FNAST scores obtained simultaneously in 45 term neonates with NAS were compared using correlation, linear regression, and receiver operating characteristic curve analysis to determine the validity, reliability, and specificity of the NAS scores.

Results The association between the NAS and M-FNAST scores was high (Spearman's correlation, 83%; linear regression, 83%), with an area under the curve of the NAS score of 1.00 (p < 0.01). A cut-off NAS score ≥4 identified NAS neonates with a sensitivity of 100% and specificity of 96%. The values of intraclass correlation, interrater agreement, and Cronbach's α were 0.63, 0.88, and 0.63, respectively.

Conclusion The new NAS scoring system is valid, reliable, physiologically based, and correlates closely with the M-FNAST score. The NAS scores may require further validation before its use in clinical practice.

Keywords

neonatal abstinence syndrome - NAS scores - withdrawal - physiological

Supplementary Material

Comment to this article:

A New Scoring System for the Assessment of Neonatal Abstinence Syndrome (Podcast)Am J Perinatol 2020; 37(S 01): e2-e2
DOI: 10.1055/s-0040-1708795

 

  • References

  • 1 Kocherlakota P. Neonatal abstinence syndrome. Pediatrics 2014; 134 (02) e547-e561
    CrossrefPubMedGoogle Scholar
  • 2 Hudak ML, Tan RC. ; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129 (02) e540-e560
    CrossrefPubMedGoogle Scholar
  • 3 McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med 2016; 375 (25) 2468-2479
    CrossrefPubMedGoogle Scholar
  • 4 Kaltenbach K. Assessment of the newborn prenatally exposed to drugs: The history. Semin Fetal Neonatal Med 2019; 24 (02) 111-114
    CrossrefPubMedGoogle Scholar
  • 5 Finnegan LP, Connaughton Jr JF, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2 (1,2): 141-158
    PubMedGoogle Scholar
  • 6 Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr (Phila) 1975; 14 (06) 592-594
    CrossrefPubMedGoogle Scholar
  • 7 Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976; 88 (4, Pt. 1): 642-645
    CrossrefPubMedGoogle Scholar
  • 8 Green M, Suffet F. The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse 1981; 8 (02) 203-213
    CrossrefPubMedGoogle Scholar
  • 9 Mehta A, Forbes KD, Kuppala VS. Neonatal abstinence syndrome management from prenatal counselling to post discharge follow-up care: Results of a national survey. Hosp Pediatr 2013; 3 (04) 317-323
    PubMedGoogle Scholar
  • 10 Finnegan L, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman R, Friedman S, Nelson N, Seidel H. eds. Pediatric Primary Care. 2nd ed. St. Louis, MO: Mosby; 1992
    Google Scholar
  • 11 Wolff K, Perez-Montejano R. Opioid neonatal abstinence syndrome: controversies and implications for practice. Curr Drug Abuse Rev 2014; 7 (01) 44-58
    CrossrefPubMedGoogle Scholar
  • 12 Schiff DM, Grossman MR. Beyond the Finnegan scoring system: novel assessment and diagnostic techniques for the opioid-exposed infant. Semin Fetal Neonatal Med 2019; 24 (02) 115-120
    CrossrefPubMedGoogle Scholar
  • 13 D'Apolito KC. Assessing neonates for neonatal abstinence: are you reliable?. J Perinat Neonatal Nurs 2014; 28 (03) 220-231
    PubMedGoogle Scholar
  • 14 Wachman EM, Grossman M, Schiff DM. , et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. J Perinatol 2018; 38 (08) 1114-1122
    CrossrefPubMedGoogle Scholar
  • 15 Kraft WK, Adeniyi-Jones SC, Chervoneva I. , et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. N Engl J Med 2017; 376 (24) 2341-2348
    CrossrefPubMedGoogle Scholar
  • 16 Jones HE, Seashore C, Johnson E. , et al. Psychometric assessment of the neonatal abstinence scoring system and the MOTHER NAS scale. Am J Addict 2016; 25 (05) 370-373
    CrossrefPubMedGoogle Scholar
  • 17 Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract 2014; 9 (01) 19
    CrossrefPubMedGoogle Scholar
  • 18 Patrick SW, Schumacher RE, Horbar JD. , et al. Improving care for neonatal abstinence syndrome. Pediatrics 2016; 137 (05) e20153835
    CrossrefPubMedGoogle Scholar
  • 19 Timpson W, Killoran C, Maranda L, Picarillo A, Bloch-Salisbury E. A Quality improvement initiative to increase scoring consistency and accuracy of the Finnegan tool: Challenges in obtaining reliable assessments of drug withdrawal in neonatal abstinence syndrome. Adv Neonatal Care 2018; 18 (01) 70-78
    CrossrefPubMedGoogle Scholar
  • 20 Jones HE, Seashore C, Johnson E, Horton E, O'Grady KE, Andringa K. Measurement of neonatal abstinence syndrome: evaluation of short forms. J Opioid Manag 2016; 12 (01) 19-23
    CrossrefPubMedGoogle Scholar
  • 21 Maguire D, Cline GJ, Parnell L, Tai CY. Validation of the Finnegan neonatal abstinence syndrome tool-short form. Adv Neonatal Care 2013; 13 (06) 430-437
    CrossrefPubMedGoogle Scholar
  • 22 Gomez Pomar E, Finnegan LP, Devlin L. , et al. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open 2017; 7 (09) e016176
    CrossrefPubMedGoogle Scholar
  • 23 Grossman MR, Berkwitt AK, Osborn RR. , et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017; 139 (06) e20263360
    PubMedGoogle Scholar
  • 24 Kocherlakota P, Qian E, Patel V, Mandru C, Vilar R. NA-S-CORE, A New Scoring System for the Management of NAS presented at Eastern Society of Pediatric Research Annual Meeting. Philadelphia. PA, March 24–26, 2017
    PubMedGoogle Scholar
  • 25 Qian E, Patel V, Mandru C, Vilar R, Kocherlakota P. NA-S-CORE New Scoring System for the Management of Neonatal Abstinence Syndrome presented at American Academy of Pediatrics Experience National Conference and Exhibition, Chicago, IL, September 16–19, 2017
    PubMed
  • 26 Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 2003; 80 (01) 99-103
    CrossrefPubMedGoogle Scholar
  • 27 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (01) 159-174
    CrossrefPubMedGoogle Scholar
  • 28 Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag 2009; 5 (01) 47-55
    PubMedGoogle Scholar
  • 29 Finnegan LP, Kron RE, Connaughton JF, Emich JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm 1975; 12 (1,2): 19-32
    PubMedGoogle Scholar
  • 30 Little PJ, Price RR, Hinton RK, Kuhn CM. Role of noradrenergic hyperactivity in neonatal opiate abstinence. Drug Alcohol Depend 1996; 41 (01) 47-54
    CrossrefPubMedGoogle Scholar
  • 31 Elliott MR, Cunliffe P, Demianczuk N, Robertson CMT. Frequency of newborn behaviours associated with neonatal abstinence syndrome: a hospital-based study. J Obstet Gynaecol Can 2004; 26 (01) 25-34
    CrossrefPubMedGoogle Scholar
  • 32 Cheshire Jr WP, Goldstein DS. The physical examination as a window into autonomic disorders. Clin Auton Res 2018; 28 (01) 23-33
    CrossrefPubMedGoogle Scholar
  • 33 van Stralen KJ, Jager KJ, Zoccali C, Dekker FW. Agreement between methods. Kidney Int 2008; 74 (09) 1116-1120
    CrossrefPubMedGoogle Scholar
  • 34 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1 (8476): 307-310
    PubMedGoogle Scholar